In the coming weeks, BHC will start a new research study that you may be eligible to participate in! This research will assess endothelial function and upright activity in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID, which is...
The Researching COVID to Enhance Recovery (RECOVER), is an Initiative of the National Institutes of Health that aims to understand, prevent, and treat post-acute sequelae of SARS-CoV-2 (PASC), including Long COVID. Bateman Horne Center was invited to partner with the...
In 2018 the Food and Drug Administration approved a physician-sponsored Investigational New Drug (IND) Application, to investigate the safety, tolerability and efficacy of CT38 in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Dr....
BHC: A Unique Clinical Research Center Of all of the places I’ve worked, BHC is the one with the greatest promise to improve the lives of those impacted by ME/CFS, FM and post-viral illnesses. Why? Because of our unique model of clinical care, research, and education....
It’s Research Week at Bateman Horne Center! This means that as part of our Mission Possible giving campaign we fill you in on why research is so important to our organization and how we are using it to improve the lives of those with ME/CFS, fibromyalgia,...
